Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15fd9c73822ad80e38eec3673024869a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 |
filingDate |
1999-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a60e2c09062efff01b1cff3bc864714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_856c4a58e245c7c5a9187ac916ed9883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_897c81115315bba2c83b902b8f3a0c4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa331803510bfce68e74edf614ef244a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37758e89f95301b50be3180e560885f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_697d15b8fc6661daf1ccc6687370d6be |
publicationDate |
2005-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
OA-11686-A |
titleOfInvention |
Group B streptococcus antigens. |
abstract |
Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection. |
priorityDate |
1998-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |